Petr Sova

Platinum(IV) Complex with Adamantylamine as Nonleaving Amine Group:  Synthesis, Characterization, and in Vitro Antitumor Activity against a Panel of Cisplatin-Resistant Cancer Cell Lines

F. Žák, Jaroslav Tuřánek, Aleš Kroutil et al. · Journal of Medicinal Chemistry · 2003 · 73 citations

Engineering, Nonleaving Amine Group, New Platinum +16

High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro

Alois Kozubı́k, Viktor Horváth, Lenka Šindlerová et al. · Biochemical Pharmacology · 2004 · 54 citations

Medicine, Cancer Treatment, Radiation Oncology +6

New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes

Jaroslav Tuřánek, Andrea Kašná, Dana Záluská et al. · Anti-Cancer Drugs · 2004 · 40 citations

Medicinal Chemistry, Promising Anti-cancer Drug, Anti-tumor Potency +15

Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway

Olga Vondálová Blanářová, Iva Jelínková, Árpád Szöőr et al. · Carcinogenesis · 2010 · 40 citations · Full text

Apoptosis, Cell Death, Cancer Biology +17

The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin

Veronika Kvardová, Roman Hrstka, Dawid Walerych et al. · Molecular Cancer · 2010 · 32 citations · Full text